miR-135b Delivered by Gastric Tumor Exosomes Inhibits FOXO1 Expression in Endothelial Cells and Promotes Angiogenesis.

[1]  Xiao-Hong Zhu,et al.  MiR-135b is a novel oncogenic factor in cutaneous melanoma by targeting LATS2 , 2019, Melanoma research.

[2]  M. Negrini,et al.  Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer , 2018, BMC Cancer.

[3]  D. Graves,et al.  FOXO1 regulates VEGFA expression and promotes angiogenesis in healing wounds , 2018, The Journal of pathology.

[4]  Jian Ma,et al.  FOXO family in regulating cancer and metabolism. , 2018, Seminars in cancer biology.

[5]  Leping Li,et al.  miR-135b-5p promotes gastric cancer progression by targeting CMTM3. , 2017, International journal of oncology.

[6]  Wei-Guo Zhu,et al.  Mechanisms controlling the anti-neoplastic functions of FoxO proteins. , 2017, Seminars in cancer biology.

[7]  T. Deguchi,et al.  Exosomes expressing carbonic anhydrase 9 promote angiogenesis. , 2017, Biochemical and biophysical research communications.

[8]  Wei Zhang,et al.  Combined aspirin and apatinib treatment suppresses gastric cancer cell proliferation , 2017, Oncology letters.

[9]  I. Retamal,et al.  Angiogenesis inhibitors in early development for gastric cancer , 2017, Expert opinion on investigational drugs.

[10]  H. Chung,et al.  High‐mobility group box‐1 contributes tumor angiogenesis under interleukin‐8 mediation during gastric cancer progression , 2017, Cancer science.

[11]  Yuanyu Wu,et al.  Progress in the treatment of advanced gastric cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[12]  Y. Ba,et al.  Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis , 2017, Nature Communications.

[13]  A. Chávez-Reyes,et al.  International Journal of Molecular Sciences Exosomes: from Garbage Bins to Promising Therapeutic Targets , 2022 .

[14]  R. D. De Mello,et al.  Angiogenesis and apatinib: a new hope for patients with advanced gastric cancer? , 2017, Future oncology.

[15]  R. Ray,et al.  Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells , 2017, Journal of Virology.

[16]  Hongming Song,et al.  miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2. , 2016, International journal of oncology.

[17]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[18]  R. Burbano,et al.  hsa-miR-29c and hsa-miR-135b differential expression as potential biomarker of gastric carcinogenesis. , 2016, World journal of gastroenterology.

[19]  R. Janknecht,et al.  Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA) , 2015, Molecular Cancer.

[20]  Chao Li,et al.  CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway. , 2015, World journal of gastroenterology.

[21]  Jigang Wang,et al.  Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways , 2015, Autophagy.

[22]  R. Simpson,et al.  Exosomes and their roles in immune regulation and cancer. , 2015, Seminars in cell & developmental biology.

[23]  Helena Carreira,et al.  Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) , 2015, The Lancet.

[24]  F. Roviello,et al.  Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience , 2015, Cancer Chemotherapy and Pharmacology.

[25]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[26]  Yanmei Xu,et al.  Exosomes: Novel Biomarkers for Clinical Diagnosis , 2015, TheScientificWorldJournal.

[27]  K. Ohyashiki,et al.  Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. , 2014, Blood.

[28]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[29]  I. Chau,et al.  Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer , 2014, Clinical Cancer Research.

[30]  Clotilde Théry,et al.  Biogenesis and secretion of exosomes. , 2014, Current opinion in cell biology.

[31]  S. Zhong,et al.  Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs , 2014, PloS one.

[32]  Julia B. Cordero,et al.  MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer , 2014, Cancer cell.

[33]  Yan-Shen Shan,et al.  Management of gastric cancer in Asia: resource-stratified guidelines. , 2013, The Lancet. Oncology.

[34]  Yih-Leong Chang,et al.  MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1 , 2013, Nature Communications.

[35]  P. Kenny,et al.  MicroRNAs in neuronal function and dysfunction , 2012, Trends in Neurosciences.

[36]  N. Raab-Traub,et al.  Microvesicles and Viral Infection , 2011, Journal of Virology.

[37]  W. Filipowicz,et al.  The widespread regulation of microRNA biogenesis, function and decay , 2010, Nature Reviews Genetics.

[38]  Y Zhang,et al.  Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[39]  S. Kaushal,et al.  Journal of Translational Medicine BioMed Central , 2008 .

[40]  S. Al-Batran,et al.  Chemotherapy for advanced gastric cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  S. Tsujitani,et al.  Angiogenesis, angiogenic factor expression and prognosis of gastric carcinoma. , 2001, Anticancer research.

[42]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.